You are on Trendlyne United States. Click here to go to India website or make United States as your default

13.14 0.52 (4.12%)

New 52W Low in past week

682.1K XNAS Volume

XNAS 19 Mar, 2025 5:30 PM (EDT)

Xencor Inc Key Metrics

Select
All financials are in USD Million and price data in USD
VIEW MORE
Low Financial Strength
11.1 / 100
Expensive Valuation
16.0 / 100
Technically Neutral
36.0 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

Xencor Inc Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '22Dec '23Dec '24Dec '25Dec '260200400Actual RevenueAvg. Estimate
Hit

Xencor Inc's Revenue was higher than average estimate 2 times in past 3 years

EPS forecast

Current EPS
-3.6
Avg. Estimate
-2.6
Low Estimate
-4.1
High Estimate
-1.4
Current EPS
Avg. Estimate
Hit

EPS is expected to grow by 27.1% in FY25

Consensus Recommendation

11 ANALYST Recommendations
BUY

Created with Highcharts 7.2.21Sell3Buy7Strong Buy

The consensus recommendation from 11 analysts for Xencor Inc is BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Xencor Inc Stock Analysis

Xencor Inc stock analysis with key metrics, changes, and trends.

Xencor Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$110.49 M36.72%negative

Annual Revenue fell 36.72%, in the last year to $110.49 M. Its sector's average revenue growth for the last fiscal year was 7.47%.

Annual Net Profit$232.62 M74.73%negative

Annual Net Profit fell 74.73% in the last year to $232.62 M. Its sector's average net profit growth for the last fiscal year was -32.39%.

Price to Earning Ratio-3.98-negative

Price to Earning Ratio is -3.98, which is negative.

Stock Price$13.14-42.27%negative

Stock Price fell 42.27% and underperformed its sector by 51.82% in the past year.

Quarterly Revenue$52.79 M3.58%positive

Quarterly Revenue rose 3.58% YoY to $52.79 M. Its sector's average revenue growth YoY for the quarter was 5.97%.

Quarterly Net profit$45.55 M74.22%negative

Quarterly Net profit fell 74.22% YoY to $45.55 M. Its sector's average net profit growth YoY for the quarter was -47.48%.

Debt to Equity Ratio0.34-positive

Debt to Equity Ratio of 0.34 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE)-34.74 %-34.74%negative

Return on Equity(ROE) for the last financial year was -34.74%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding72.82 %-1.19%negative

Mutual Fund Holding decreased by 1.19% in the last quarter to 72.82.

Promoter Share Holding1.66 %0.29%positive

Promoter Share Holding increased by 0.29% in the most recent quarter to 1.66%.

Interest Coverage Ratio-5.41-negative

Interest Coverage Ratio is -5.41, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding106.77 %0%neutral

Institutional Holding remained the same in the last quarter at 106.77%.

VIEW LESS


Loading data..

Xencor Inc - Company Profile

What does Xencor Inc do?

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Xencor Inc Management structure

All Gross Remunerations are in USD
Mr. John J. Kuch
Senior Vice President, Chief Financial Officer and Principal Accounting Officer
-
2024
Gross Remuneration
Year
Mr. Bart Jan Cornelissen
Senior Vice President and Chief Financial Officer
-
2024
Gross Remuneration
Year
Dr. Bassil I. Dahiyat, PhD.
Director, President and Chief Executive Officer
-
2024
Gross Remuneration
Year

Xencor Inc Board of directors

All Gross Remunerations are in USD
Mr. Todd E. Simpson
Director
-
2025
Gross Remuneration
Year

Xencor Inc FAQ

How is Xencor Inc today?
Xencor Inc today is trading in the green, and is up by 4.12% at 13.14.
Xencor Inc is currently trading up 4.12% on an intraday basis. In the past week the stock rose 0.08%. stock has been down -45.27% in the past quarter and fell -42.27% in the past year. You can view this in the overview section.